Quantitative Analysis of Cardiac 3-L-nitrotyrosine During Acute Allograft Rejection in an Experimental Heart Transplantation
Overview
Affiliations
Background: Recent studies have shown that nitric oxide interacts with superoxide to form peroxynitrite, a potent oxidant that modifies cellular proteins producing 3-L-nitrotyrosine (N-Tyr). This study was designed to evaluate N-Tyr quantitatively with high-performance liquid chromatography (HPLC) during cardiac allograft rejection.
Methods: Rat transplanted hearts (allogeneic or syngeneic grafts) were examined with HPLC analysis, immunohistochemistry for N-Tyr, and histological studies on 0, 1, 3, and 7 days after transplantation.
Results: No histological rejection was found in syngeneic grafts, or day 0 or 1 allografts. HPLC demonstrated that N-Tyr in allografts increased on day 1 and continued to increase through day 7, while N-Tyr was not detected in any syngeneic grafts. Immunostaining of the allografts did not show N-Tyr on day 1.
Conclusion: These results demonstrate that N-Tyr shows a time-dependent accumulation in cardiac allografts during acute rejection. N-Tyr detection using HPLC may be an useful maker for early diagnosis of acute rejection before pathological rejection occurs.
Regulation of Chemokine Function: The Roles of GAG-Binding and Post-Translational Nitration.
Thompson S, Martinez-Burgo B, Sepuru K, Rajarathnam K, Kirby J, Sheerin N Int J Mol Sci. 2017; 18(8).
PMID: 28771176 PMC: 5578082. DOI: 10.3390/ijms18081692.
Catalytic peroxynitrite decomposition improves reperfusion injury after heart transplantation.
Szabo G, Loganathan S, Merkely B, Groves J, Karck M, Szabo C J Thorac Cardiovasc Surg. 2012; 143(6):1443-9.
PMID: 22401641 PMC: 3586276. DOI: 10.1016/j.jtcvs.2012.02.008.
The complex role of iNOS in acutely rejecting cardiac transplants.
Pieper G, Roza A Free Radic Biol Med. 2008; 44(8):1536-52.
PMID: 18291116 PMC: 2443548. DOI: 10.1016/j.freeradbiomed.2008.01.020.
Nitric oxide and peroxynitrite in health and disease.
Pacher P, Beckman J, Liaudet L Physiol Rev. 2007; 87(1):315-424.
PMID: 17237348 PMC: 2248324. DOI: 10.1152/physrev.00029.2006.
Ferdinandy P, Schulz R Br J Pharmacol. 2003; 138(4):532-43.
PMID: 12598407 PMC: 1573696. DOI: 10.1038/sj.bjp.0705080.